Acute myeloid leukemia cells harboring MLL fusion genes or with the acute promyelocytic leukemia phenotype are sensitive to the Bcl-2-selective inhibitor ABT-199-Reference-Cited by-同舟云学术

Acute myeloid leukemia cells harboring MLL fusion genes or with the acute promyelocytic leukemia phenotype are sensitive to the Bcl-2-selective inhibitor ABT-199

Published:2014-02-17 Issue:7 Volume:28 Page:1557-1560
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Niu X,Wang G,Wang Y,Caldwell J T,Edwards H,Xie C,Taub J W,Li C,Lin H,Ge Y

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/leu201472.pdf

Reference10 articles.

1. Siegel R, Naishadham D, Jemal A . Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11–30.

2. Rubnitz JE, Inaba H, Dahl G, Ribeiro RC, Bowman WP, Taub J et al. Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial. Lancet Oncol 2010; 11: 543–552.

3. Saxena A, Viswanathan S, Moshynska O, Tandon P, Sankaran K, Mcl-1 Sheridan DP . and Bcl-2/Bax ratio are associated with treatment response but not with Rai stage in B-cell chronic lymphocytic leukemia. Am J Hematol 2004; 75: 22–33.

4. Lauria F, Raspadori D, Rondelli D, Ventura MA, Fiacchini M, Visani G et al. High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate. Leukemia 1997; 11: 2075–2078.

5. Davids MS, Letai A . Targeting the B-cell lymphoma/leukemia 2 family in cancer. J Clin Onco 2012; 30: 3127–3135.

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heme oxygenase 1 confers gilteritinib resistance in FLT3-ITD acute myeloid leukemia in a STAT6-dependent manner;Cancer Cell International;2025-04-04

2. Mitoxantrone-liposome Sensitizes FLT3-ITD Acute Myeloid Leukemia to Gilteritinib Treatment;Journal of Cancer;2025-02-28

3. ONC213: a novel strategy to resensitize resistant AML cells to venetoclax through induction of mitochondrial stress;Journal of Experimental & Clinical Cancer Research;2025-01-09

4. First case of acute promyelocytic leukemia with TFG-RARA achieved complete remission treated with venetoclax and all-trans retinoic acid;Hematology;2024-11-28

5. Panobinostat sensitizes AraC-resistant AML cells to the combination of azacitidine and venetoclax;Biochemical Pharmacology;2024-10